UNSPSC 51393409: Xanoxic acid

This classification denotes a bronchodilator, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S6V5I726MH. European Medicines Agency schedules Xanoxic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00094MIG. Xanoxic acid generally arises in the molecular formula C17H14O5. The term XANOXIC ACID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, no. 10 1975, list 15.) Most nations schedule xanoxic acid under HS 29329985 and SITC 51569.

As of Q4 2014, XANOXIC ACID remains the US FDA Preferred Term for this commodity. Xanoxic acid bears US NLM identifiers UMLS ID C2825724 and NCI Concept Code C81676. SMILES: O1C2C(C(=O)C3C1CCC(C3)C(=O)O)CC(OC(C)C)CC2.

UNSPSC 51393409 Xanoxic acid (Commodity) does not map to the work state and local governments are actually buying under this code. The two recent opportunities tagged to this code procure naloxone and drug deactivation systems (Seminole County, Florida) and pharmacy benefit program management services (Texas Health and Human Services Commission), neither of which relates to xanoxic acid as a chemical commodity. The code shows no relevant recent activity aligned with its nominal scope.

The mismatch between the code name and the posted solicitations reflects either a cataloging error in the state or local procurement system or a deliberate but non-standard tagging choice by the issuing bodies. State and local procurement professionals evaluating this code should verify the actual commodity classification in source RFPs or RFQs before pursuing opportunities, as the UNSPSC tag alone does not reliably indicate what is being bought.